Literature DB >> 27733418

Cocaine-induced very late stent thrombosis.

Priyank Shah1, Rahul Vasudev2, Ahmad Hisham Abuarqoub3, Fayez Shamoon1.   

Abstract

Cocaine misuse is a known cause of acute coronary syndrome (ACS). Management of these patients has always been a challenge due to medication compliance and eventual risk of stent thrombosis. However, even cocaine misusers who are compliant with dual antiplatelet therapy have been reported to have stent thrombosis. All cases of cocaine-induced stent thrombosis reported in the literature have occurred within first year of stent placement (acute, subacute or late). We report a first case of very late stent thrombosis in a 54-year-old active cocaine misuser who presented with ST segment elevation myocardial infarction, which was successfully managed with percutaneous transluminal coronary angioplasty. A review of all the reported cases of cocaine-induced stent thrombosis is also discussed. Given the high mortality associated with stent thrombosis, treatment option for cocaine misusers presenting with ACS should be conservative when possible. If percutaneous coronary intervention is needed, bare metal stent should be preferred. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27733418      PMCID: PMC5073699          DOI: 10.1136/bcr-2016-216557

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  13 in total

1.  Mechanisms of very late stent thrombosis after drug-eluting stent implantation: findings from coronary angioscopy and optical coherence tomography.

Authors:  Hiroki Ikenaga; Masaharu Ishihara; Kazuoki Dai; Yasuharu Nakama; Takayuki Ohtani
Journal:  JACC Cardiovasc Imaging       Date:  2011-11

Review 2.  Cardiovascular effects of cocaine.

Authors:  Bryan G Schwartz; Shereif Rezkalla; Robert A Kloner
Journal:  Circulation       Date:  2010-12-14       Impact factor: 29.690

Review 3.  Management of cocaine-associated chest pain and myocardial infarction: a scientific statement from the American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology.

Authors:  James McCord; Hani Jneid; Judd E Hollander; James A de Lemos; Bojan Cercek; Priscilla Hsue; W Brian Gibler; E Magnus Ohman; Barbara Drew; George Philippides; L Kristin Newby
Journal:  Circulation       Date:  2008-03-17       Impact factor: 29.690

4.  Increased incidence of stent thrombosis in patients with cocaine use.

Authors:  Gudjon Karlsson; Jalees Rehman; Vijay Kalaria; Jeffrey A Breall
Journal:  Catheter Cardiovasc Interv       Date:  2007-06-01       Impact factor: 2.692

5.  Effects of cocaine on human platelets in healthy subjects.

Authors:  S H Rezkalla; J J Mazza; R A Kloner; V Tillema; S H Chang
Journal:  Am J Cardiol       Date:  1993-07-15       Impact factor: 2.778

6.  Activation of human platelets by cocaine.

Authors:  A D Kugelmass; A Oda; K Monahan; C Cabral; J A Ware
Journal:  Circulation       Date:  1993-09       Impact factor: 29.690

7.  A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.

Authors:  M B Leon; D S Baim; J J Popma; P C Gordon; D E Cutlip; K K Ho; A Giambartolomei; D J Diver; D M Lasorda; D O Williams; S J Pocock; R E Kuntz
Journal:  N Engl J Med       Date:  1998-12-03       Impact factor: 91.245

Review 8.  Increased incidence of in-stent thrombosis related to cocaine use: case series and review of literature.

Authors:  Sarabjeet Singh; Rohit Arora; Ahmad Khraisat; Kamna Handa; Amol Bahekar; Atul Trivedi; Sandeep Khosla
Journal:  J Cardiovasc Pharmacol Ther       Date:  2007-12       Impact factor: 2.457

9.  Cocaine use is associated with an increased risk of stent thrombosis after percutaneous coronary intervention.

Authors:  Scott A McKee; Robert J Applegate; John R Hoyle; Matthew T Sacrinty; Michael A Kutcher; David C Sane
Journal:  Am Heart J       Date:  2007-07       Impact factor: 4.749

10.  Acute stent thrombosis in the setting of cocaine abuse following percutaneous coronary intervention.

Authors:  John N Makaryus; Ariy Volfson; Victor Azer; Elena Bogachuk; Alexander Lee
Journal:  J Interv Cardiol       Date:  2008-09-04       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.